Literature DB >> 2817456

Epidural clonidine analgesia following surgery: phase I.

J C Eisenach1, S Z Lysak, C M Viscomi.   

Abstract

Epidurally administered clonidine has been reported to produce postoperative analgesia. To assess the efficacy, safety, and appropriate dose of epidural clonidine for postoperative analgesia, clonidine (range, 100-900 micrograms in 100-micrograms increments) was injected in 22 patients following abdominal surgery or total knee arthroplasty (TKA). Clonidine produced analgesia, as measured by change in verbal pain scores and supplemental iv morphine usage. The largest doses examined (700-900 micrograms) produced complete pain relief for 5.0 +/- 0.8 h (mean +/- SEM; range 2-11 h), without other sensory or motor blockade. Clonidine also produced dose dependent decreases in blood pressure, being less following small (100-300 micrograms) and large (700-900 micrograms) doses than following intermediate (400-600 micrograms) doses. Six patients required iv ephedrine for treatment of blood pressure decrease of greater than 30%. Clonidine decreased heart rate 10-30% and produced transient sedation. Oxyhemoglobin saturation, serum glucose, and arterial blood gas tensions were not altered by clonidine, whereas there was a small (28%) dose-independent decrease in serum cortisol following clonidine injection. Clonidine was absorbed in a dose-dependent manner into the systemic circulation, with plasma concentrations 0.1-3.3 ng/ml 1 h following injection. These results suggest that hemodynamic depression and short-lasting analgesia may limit the usefulness of bolus epidural clonidine analgesia in the postoperative setting.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2817456     DOI: 10.1097/00000542-198911000-00003

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  26 in total

1.  Sympathetic mechanisms in postoperative pain.

Authors:  J B Forrest
Journal:  Can J Anaesth       Date:  1992-07       Impact factor: 5.063

2.  Intraoperative clonidine enhances postoperative morphine patient-controlled analgesia.

Authors:  M F De Kock; G Pichon; J L Scholtes
Journal:  Can J Anaesth       Date:  1992-07       Impact factor: 5.063

3.  [Epidural and intrathecal administration of alpha 2-adreno-ceptor agonists for postoperative pain relief].

Authors:  M G Rockemann; W Seeling
Journal:  Schmerz       Date:  1996-04-25       Impact factor: 1.107

4.  Clinical study of epidural analgesia with clonidine and sumatriptan in posthysterectomy.

Authors:  Z Liu; Y Tian; C Zhang; S Jin
Journal:  J Tongji Med Univ       Date:  1997

5.  The role of clonidine and alpha 2-agonists for postoperative analgesia.

Authors:  A N Sandler
Journal:  Can J Anaesth       Date:  1996-12       Impact factor: 5.063

6.  Oral clonidine reduces postoperative PCA morphine requirements.

Authors:  J Park; J Forrest; R Kolesar; D Bhola; S Beattie; C Chu
Journal:  Can J Anaesth       Date:  1996-09       Impact factor: 5.063

7.  Efficacy and Safety of Clonidine as an Adjuvant to Bupivacaine for Caudal Analgesia in Paediatric Infra-Umbilical Surgeries.

Authors:  Samita Priolkar; Shirley Ann D'Souza
Journal:  J Clin Diagn Res       Date:  2016-09-01

8.  Does preoperative oral clonidine inhibit salivary secretion during general anesthesia?

Authors:  R Numazawa; T Mayumi; O Kemmotsu
Journal:  J Anesth       Date:  1993-07       Impact factor: 2.078

9.  Effects of dexmedetomidine on hemodynamics and respiration in intubated, spontaneously breathing patients after endoscopic submucosal dissection for cervical esophageal or pharyngeal cancer.

Authors:  Chika Ishibashi; Masakazu Hayashida; Yusuke Sugasawa; Keisuke Yamaguchi; Natsumi Tomita; Yoshiaki Kajiyama; Eiichi Inada
Journal:  J Anesth       Date:  2016-04-28       Impact factor: 2.078

Review 10.  Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis.

Authors:  Carolyn A Fairbanks; Laura S Stone; George L Wilcox
Journal:  Pharmacol Ther       Date:  2009-04-23       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.